Biolegend, 141720, PE/Cyanine7 anti-mouse CD206 (MMR) Antibody, 100μg

CD206, also known as mannose receptor (MR), is a 175 kD type I membrane protein. It is a pattern recognition receptor (PRR) belonging to the C-type lectin superfamily. MR is expressed on macrophages, dendritic cells, Langerhans cells, and hepatic or lymphatic endothelial cells. MR recognizes a range of microbial carbohydrates bearing mannose, fucose, or N-acetyl glucosamine through its C-type lectin-like carbohydrate recognition domains, sulfated carbohydrate antigens through its cysteine-rich domain, and collagens through its fibronectin type II domain. MR mediates endocytosis and phagocytosis as well as activation of macrophages and antigen presentation. It plays an important role in host defense and provides a link between innate and adaptive immunity. Recently, MR on lymphatic endothelial cells was found to be involved in leukocyte trafficking and a contributor to the metastatic behavior of cancer cells. It suggests that MR may be a potential target in controlling inflammation and cancer metastasis by targeting the lymphatic vasculature.
100μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Rat
Immunogen: Recombinant mouse CD206 (MMR)
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography and conjugated with PE/Cyanine7 under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: ICFC - Quality tested FC - Verified
Recommended Usage: Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Blue Laser (488 nm)Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes: Clone C068C2 recognizes a region similar to clone MR5D3, based on the ability of the clones to block each other. Additional reported applications (for the relevant formats) include: spatial biology (IBEX)4,5.
Application References(PubMed link indicates BioLegend citation): Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed Yang X, et al. 2015. PNAS. 112:2900. PubMed Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations: Sagnella SM, et al. 2020. Cancer Cell. 37(3):354-370. PubMed Solier S, et al. 2023. Int J Mol Sci. 24:. PubMed Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed Schwarz N, et al. 2023. FASEB J. 37:e22846. PubMed Vanneste D, et al. 2023. Nat Immunol. 24:827. PubMed Chen Y, et al. 2023. J Nanobiotechnology. 21:98. PubMed He Q, et al. 2023. Parasit Vectors. 16:139. PubMed Rosina M, et al. 2022. Cell Metab. 34:533. PubMed Fang C, et al. 2022. J Pathol. 256:310. PubMed Xin B, et al. 2022. Hepatology. 76:630. PubMed Liang Y, et al. 2022. Theranostics. 12:7729. PubMed Yu J, et al. 2022. Nat Commun. 13:7903. PubMed Tunali G, et al. 2023. J Clin Invest. :. PubMed Zhang M, et al. 2020. Evid Based Complement Alternat Med. 8591892:2020. PubMed Zheng W, et al. 2021. Wellcome Open Research. 6:52. PubMed Accarias S, et al. 2020. J Cell Sci. 133:. PubMed Hu J, et al. 2021. Sci Adv. 7:. PubMed Mason HD, et al. 2021. JCI Insight. 6:e149229. PubMed Sepe JJ, et al. 2022. JACC Basic Transl Sci. 7:915. PubMed Hreha TN, et al. 2020. Front Immunol. 1.597916667. PubMed Zhou X, et al. 2022. Front Pharmacol. 13:887263. PubMed Ma C, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed Brestoff JR, et al. 2021. Cell Metab. 33:270. PubMed Wu T, et al. 2021. J Exp Med. :218. PubMed Nagai Y, et al. 2019. Front Immunol. 10:174. PubMed Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed Shen H, et al. 2022. Nat Commun. 13:6030. PubMed Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed Ling X, et al. 2021. ACS Nano. 15:765. PubMed Goggi JL, et al. 2020. Mol Imaging Biol. 22:1392. PubMed Zheng Y, et al. 2022. Front Pharmacol. 12:816032. PubMed Chen D, et al. 2020. Cancer Immunol Res. 8:883. PubMed Al Mamun A, et al. 2019. Neurochem Int. 127:148. PubMed Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed Kennedy EM, et al. 2022. Nat Commun. 13:5907. PubMed Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed Gubin MM, et al. 2018. Cell. 175:1014. PubMed Liu P, et al. 2022. iScience. 25:103867. PubMed Andriessen EMMA, et al. 2021. EMBO Mol Med. 13:e11754. PubMed Wang G, et al. 2021. Cell Host Microbe. 29(5):777-791.e6. PubMed Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed Pizzurro GA, et al. 2021. Cancers (Basel). 13:. PubMed Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed Chhatbar C et al. 2018. Cell reports. 25(1):118-129 . PubMed Weinstock NI, et al. 2020. Neuron. 107(1):65-81. PubMed Lam KC, et al. 2021. Cell. 184:5338. PubMed Heinen A, et al. 2019. Mol Ther. 27:46:00. PubMed Ravussin A, et al. 2018. Cell Rep. 24:1085. PubMed Huang T, et al. 2022. Nat Commun. 13:3489. PubMed Panagi M, et al. 2020. Theranostics. 10:1910. PubMed Molgora M, et al. 2020. Cell. 182:886. PubMed Knox T, et al. 2019. Sci Rep. 9:6136. PubMed Zhang L, et al. 2019. Front Immunol. 1.381944444. PubMed Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed Scholz A, et al. 2016. EMBO Mol Med. 8: 39 - 57. PubMed Silva HM, et al. 2019. J Exp Med. 216:786. PubMed Piirainen S, et al. 2021. Glia. 69:2459. PubMed Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed Güç E, et al. 2020. Methods Enzymol. 91:632. PubMed Zhu Y et al. 2017. The Journal of Neuroscience. 37(9):2362-2376 . PubMed Zhang SJ, et al. 2021. Adv Sci (Weinh). 8:2003410. PubMed
RRID: AB_2562247 (BioLegend Cat. No. 141719) AB_2562248 (BioLegend Cat. No. 141720)
Structure: Type I transmembrane protein, 175 kD, C-type lectin superfamily
Distribution: Macrophages, dendritic cells, Langerhans cells, liver endothelial cells
Function: Pathogen recognition, endocytosis and phagocytosis, antigen presentation
Ligand/Receptor: Antigen containing mannose, fucose, or an N-acetyl glucosamine
Cell Type: Dendritic cells, Endothelial cells, Langerhans cells, Macrophages
Biology Area: Cell Biology, Immunology, Innate Immunity, Signal Transduction
Molecular Family: CD Molecules
Antigen References: 1. Wileman TE, et al. 1986. P. Natl. Acad. Sci. USA 83:2501. 2. Apostolopoulos V, et al. 2001. Curr. Mol. Med. 1:469. 3. Burgdorf S, et al. 2006. J. Immunol. 176:6770. 4. McKenzie EJ, et al. 2007. J. Immunol. 178:4975.
Gene ID: 17533
UniProt: View information about CD206 on UniProt.org
Clone: C068C2
Regulatory Status: RUO
Other Names: MMR (macrophage mannose receptor), MR (mannose receptor), MRC1
Isotype: Rat IgG2a, κ
Q: Why is mouse CD206 stained intracellularly and not via surface staining?
A: Typically, mouse CD206 surface level is relatively low under normal conditions and so intracellular staining protocol is required to get better signal.